Literature DB >> 21925074

The use of steroids in the treatment of severe sepsis and septic shock.

Baruch M Batzofin1, Charles L Sprung, Yoram G Weiss.   

Abstract

Sepsis and septic shock remain major causes of mortality and morbidity worldwide. Previously, high dose corticosteroids were used to dampen the inflammatory response but studies and meta-analyses showed this to be of no benefit and possibly detrimental. Subsequently, low dose corticosteroids were used in the treatment of sepsis and septic shock with the hypothesis that these conditions are associated with relative adrenal insufficiency. Although some studies showed promising results larger studies and meta-analyses have failed to reproduce these effects and the use of corticosteroids in the treatment of sepsis and septic shock remains controversial. We review the current literature and guidelines regarding low dose corticosteroid use in the management of sepsis and septic shock.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925074     DOI: 10.1016/j.beem.2011.05.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  8 in total

Review 1.  The role of bacterial translocation in sepsis: a new target for therapy.

Authors:  Assaf Potruch; Asaf Schwartz; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2022-05-09       Impact factor: 4.802

2.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 3.  Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis.

Authors:  M Volbeda; J Wetterslev; C Gluud; J G Zijlstra; I C C van der Horst; F Keus
Journal:  Intensive Care Med       Date:  2015-06-23       Impact factor: 17.440

Review 4.  A review of equine sepsis.

Authors:  S Taylor
Journal:  Equine Vet Educ       Date:  2015-01-14       Impact factor: 1.063

5.  The immune response: targets for the treatment of severe sepsis.

Authors:  Aline M Bernard; Gordon R Bernard
Journal:  Int J Inflam       Date:  2012-12-03

Review 6.  The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.

Authors:  Cristina Rosário; Gisele Zandman-Goddard; Esther G Meyron-Holtz; David P D'Cruz; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-08-22       Impact factor: 8.775

7.  Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: modulation by the stress hormones.

Authors:  Nicola Maggio; Efrat Shavit-Stein; Amir Dori; Ilan Blatt; Joab Chapman
Journal:  Front Mol Neurosci       Date:  2013-12-04       Impact factor: 5.639

8.  A novel nomogram model for differentiating Kawasaki disease from sepsis.

Authors:  Xiao-Ping Liu; Yi-Shuang Huang; Ho-Chang Kuo; Han-Bing Xia; Wei-Dong Huang; Xin-Ling Lang; Chun-Yi Liu; Xi Liu
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.